Fermelanta
Fermelanta (Япония, с октября 2022 г.) получает с помощью микроорганизмов ценные вещества растительного происхождения, заменяя выращивание растений и экстракцию микробной ферментацией. Ключевая технология — введение и экспрессия в клетках-продуцентах генов, ранее в них не использовавшихся, чтобы микроорганизмы синтезировали чужеродные метаболиты для промышленности. Целевые природные молекулы …
Профиль
Fermelanta, Inc. is a Japan-based biomanufacturing/synthetic biology startup engineering fast-growing E. coli to ferment and produce plant secondary metabolites (rare compounds) via multi-step biosynthetic pathways enabled by introducing 20+ heterologous genes and tightly controlling enzyme expression. Founded in 2022; headquartered in Nonoichi, Ishikawa, with Tokyo and a Silicon Valley (Palo Alto) presence. It is privately held (not listed). Series A (end of Aug 2025) raised JPY 2.0 billion led by Universal Materials Incubator and Beyond Next Ventures; seed was about JPY 800 million. Total funding reported JPY 4.8 billion. Employees ~45 (as of Aug 2025). Key developments: a lab-scale to pilot-scale scale-up with a planned 3,000 L fermentation pilot plant due May 2026; PoC includes high-yield (S)-reticuline production in Oct 2025 and ongoing scale-up with external CDMOs; company is active in 2025–2026.
Sources#
- Fermelanta, Inc. | NEDO
- ファーメランタ株式会社｜合成生物学×発酵で植物二次代謝産物を製造する石川発スタートアップ | cdmo.jp — 2026-04-15
- Japanese biomanufacturing startup Fermelanta raises $13.6m — 2025-08-29
- Fermelanta deploys microbes to make rare phytochemicals at scale — 2026-04-06
- Microbial production of useful compounds by multistep gene introduction system（Fermelanta, Inc.）
- Building Industry Beyond Research – Japan’s Fermelanta Pioneering the Future of Synthetic Biology | Beyond Next Ventures — 2026-05-12
- Fermelanta is using fermentation to create safer, cost-effective alternatives to chemicals | Interviews - JETRO Global Connection - Japan External Trade Organization - JETRO
- Japanese Biotech Firm, Fermelanta Raises ¥2 Billion in Series A to Produce Rare Natural Compounds via Fermentation, Pilot Plant Set for 2026 Completion – FoovoBridge — 2025-09-26
- Отрасль
- Альтернативные белки, Промышленная химия, Семена и генетика
- Темы
- Платформы синтетической биологии и биопроизводство, Гибридные семена и селекция, Растительные мясо, молоко и яйцо
- Роль
- Производитель — “…detailing what the company manufactures or supplies and the services it offers. - ** ** — Fermelanta, Inc. is…”
Биорешения, которые поставляет 0
Пока не указана поставщиком в решениях с доказательствами.
Что предлагают
Компания не публикует продукты и услуги — узнаем через знакомство.
Новости и статус 6
- 2026-05-27 ファーメランタ、微生物発酵で希少天然成分を開発｜サプリメント用途から市場投入を視野【インタビュー】 - Foovo -フードテックニュースの専門メディア-Fermelanta is a Kanazawa-based biotech startup that uses synthetic biology to produce rare, high-value natural compounds (such as alkaloids, flavonoids, and carotenoids) that are hard to make chemically, by engineering E. coli and running multi-gene pathways …
- 2025-11-01 Epistra and Hitachi leverage AI to achieve one of the world's largest yields and up to a 73% reduction in lab experiment iterations in the production of “(S)-Reticuline,” a pharmaceutical intermediate from Fermelanta : November 27, 2025Fermelanta is a synthetic biology startup (founded 2022) developing a fermentation-based platform using engineered E. coli to produce high-value compounds (pharmaceuticals, cosmetics, food additives), and has raised over 4 billion yen in funding and grants.
- 2025-08-29 ファーメランタ、シリーズAラウンドで20億円の資金調達を実施し、 累計調達額は48億円に | ファーメランタ株式会社のプレスリリースFermelanta (ファーメランタ) is a Ishikawa-based startup using synthetic biology to produce rare, natural-derived compounds via microbial fermentation, announced a Series A funding of 2 billion yen (total now 4.8 billion yen including prior grants), with new and …
- 2026-06-12 ファーメランタ、シリーズAラウンドで20億円調達──合成生物学による希少成分の発酵生産へ前進 - Startup News | KEPPLE（ケップル）Fermelanta is a Kobe-area biotech startup applying synthetic biology to produce scarce plant-derived compounds via engineered microbial fermentation, successfully raising 2 billion yen in Series A to scale R&D and pilot production, with total funding reaching …
- 2026-04-06 Fermelanta deploys microbes to make rare phytochemicals at scaleFermelanta is a Japanese startup that uses a multi-gene engineering platform to insert dozens of plant-related genes into E. coli, enabling scalable microbial production of rare plant phytochemicals and fragrances—beyond what traditional single-gene approaches …
- 2026-06-15 微生物に植物遺伝子を20個導入し希少成分を量産する日本発スタートアップ「Fermelanta」 - 先端農業マガジンFermelanta is a Japan-born biotech startup that has developed a proprietary tool to insert up to 20 plant-derived genes into a single bacterial cell, enabling one-step fermentation to producе rare plant compounds without CRISPR-based edits. The company aims to …
Связи: владельцы, партнёры, аналоги
Владельцы и инвесторы 2
| инвестор | Beyond Next Ventures Inc |
| инвестор | Plug and Play Japan |
Похожие компании
Innovation Labo · GF FERMENTECH Inc. / 지에프퍼멘텍 · GeneFerm Biotechnology Co., Ltd. · Mianyang Habio Bioengineering Co., Ltd · Spiber Inc. · 万田発酵（株） · Euglena Co., Ltd. - 株式会社ユーグレナ · Yakult Honsha Co., Ltd.
Реквизиты и контакты
Контакты, руководители и юридические данные доступны участникам.
Войти как участник